RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer: Concordance With the "Standard" Testing Method From Tumor Tissue and Review of Associated Timelines and Costs
Latest Information Update: 05 Jul 2023
At a glance
- Drugs ERY-ASP (Primary) ; Antineoplastics
- Indications Adenocarcinoma; Colorectal cancer; Pancreatic cancer
- Focus Pharmacodynamics
Most Recent Events
- 07 Jun 2023 Status changed from recruiting to completed.
- 07 Jun 2023 Results of circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naive metastatic colorectal cancer, published in the European Journal of Cancer
- 09 Jul 2020 New trial record